Concurrent use of antidepressants and propranolol: Case report and theoretical considerations

Charles Nemeroff, D. L. Evans

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

The therapeutic indications for propranolol have been steadily increasing in recent years. Propranolol and other β-adrenergic blocking agents are now generally acknowledged to be helpful in the management of hypertension, certain cardiac arrhythmias, migraine, essential tremor, angina pectoris, and most recently, immediately after myocardial infarction (Frishman, 1981; Norwegian Multicenter Study Group, 1982). Because of the myriad clinical settings in which propranolol has been found to be of benefit, the interactions of these drugs with other commonly utilized pharmacological agents is of great pragmatic interest. In this report we describe the successful concomitant clinical use of propranolol and an antidepressant drug. This finding is also of interest because of recent theories concerning the mechanism of action of antidepressant drugs. Because propranolol readily penetrates into the CNS, it blocks β-adrenergic receptors in both the periphery and the CNS (Weiner, 1980). Much attention has been focused recently on the effects of long-term antidepressant therapy on central β-adrenergic receptors in the brain as a possible mechanism of action of these drugs. The concurrent use of propranolol and an antidepressant drug in the patient described in this report did not attenuate the therapeutic effects of the antidepressant.

Original languageEnglish
Pages (from-to)237-241
Number of pages5
JournalBiological Psychiatry
Volume18
Issue number2
StatePublished - Jan 1 1983
Externally publishedYes

Fingerprint

Propranolol
Antidepressive Agents
Adrenergic Receptors
Essential Tremor
Adrenergic Antagonists
Angina Pectoris
Therapeutic Uses
Migraine Disorders
Drug Interactions
Multicenter Studies
Cardiac Arrhythmias
Myocardial Infarction
Pharmacology
Hypertension
Brain
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Concurrent use of antidepressants and propranolol : Case report and theoretical considerations. / Nemeroff, Charles; Evans, D. L.

In: Biological Psychiatry, Vol. 18, No. 2, 01.01.1983, p. 237-241.

Research output: Contribution to journalArticle

@article{f523e901768d4b2f82f7cf5ad1351530,
title = "Concurrent use of antidepressants and propranolol: Case report and theoretical considerations",
abstract = "The therapeutic indications for propranolol have been steadily increasing in recent years. Propranolol and other β-adrenergic blocking agents are now generally acknowledged to be helpful in the management of hypertension, certain cardiac arrhythmias, migraine, essential tremor, angina pectoris, and most recently, immediately after myocardial infarction (Frishman, 1981; Norwegian Multicenter Study Group, 1982). Because of the myriad clinical settings in which propranolol has been found to be of benefit, the interactions of these drugs with other commonly utilized pharmacological agents is of great pragmatic interest. In this report we describe the successful concomitant clinical use of propranolol and an antidepressant drug. This finding is also of interest because of recent theories concerning the mechanism of action of antidepressant drugs. Because propranolol readily penetrates into the CNS, it blocks β-adrenergic receptors in both the periphery and the CNS (Weiner, 1980). Much attention has been focused recently on the effects of long-term antidepressant therapy on central β-adrenergic receptors in the brain as a possible mechanism of action of these drugs. The concurrent use of propranolol and an antidepressant drug in the patient described in this report did not attenuate the therapeutic effects of the antidepressant.",
author = "Charles Nemeroff and Evans, {D. L.}",
year = "1983",
month = "1",
day = "1",
language = "English",
volume = "18",
pages = "237--241",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Concurrent use of antidepressants and propranolol

T2 - Case report and theoretical considerations

AU - Nemeroff, Charles

AU - Evans, D. L.

PY - 1983/1/1

Y1 - 1983/1/1

N2 - The therapeutic indications for propranolol have been steadily increasing in recent years. Propranolol and other β-adrenergic blocking agents are now generally acknowledged to be helpful in the management of hypertension, certain cardiac arrhythmias, migraine, essential tremor, angina pectoris, and most recently, immediately after myocardial infarction (Frishman, 1981; Norwegian Multicenter Study Group, 1982). Because of the myriad clinical settings in which propranolol has been found to be of benefit, the interactions of these drugs with other commonly utilized pharmacological agents is of great pragmatic interest. In this report we describe the successful concomitant clinical use of propranolol and an antidepressant drug. This finding is also of interest because of recent theories concerning the mechanism of action of antidepressant drugs. Because propranolol readily penetrates into the CNS, it blocks β-adrenergic receptors in both the periphery and the CNS (Weiner, 1980). Much attention has been focused recently on the effects of long-term antidepressant therapy on central β-adrenergic receptors in the brain as a possible mechanism of action of these drugs. The concurrent use of propranolol and an antidepressant drug in the patient described in this report did not attenuate the therapeutic effects of the antidepressant.

AB - The therapeutic indications for propranolol have been steadily increasing in recent years. Propranolol and other β-adrenergic blocking agents are now generally acknowledged to be helpful in the management of hypertension, certain cardiac arrhythmias, migraine, essential tremor, angina pectoris, and most recently, immediately after myocardial infarction (Frishman, 1981; Norwegian Multicenter Study Group, 1982). Because of the myriad clinical settings in which propranolol has been found to be of benefit, the interactions of these drugs with other commonly utilized pharmacological agents is of great pragmatic interest. In this report we describe the successful concomitant clinical use of propranolol and an antidepressant drug. This finding is also of interest because of recent theories concerning the mechanism of action of antidepressant drugs. Because propranolol readily penetrates into the CNS, it blocks β-adrenergic receptors in both the periphery and the CNS (Weiner, 1980). Much attention has been focused recently on the effects of long-term antidepressant therapy on central β-adrenergic receptors in the brain as a possible mechanism of action of these drugs. The concurrent use of propranolol and an antidepressant drug in the patient described in this report did not attenuate the therapeutic effects of the antidepressant.

UR - http://www.scopus.com/inward/record.url?scp=0020681758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020681758&partnerID=8YFLogxK

M3 - Article

C2 - 6830933

AN - SCOPUS:0020681758

VL - 18

SP - 237

EP - 241

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 2

ER -